TCF7L2 rs4655595: Understanding Your Genetic Risk Profile
The rs4655595 variant is a common genetic change located within the TCF7L2 gene. It is recognized in scientific literature for its association with an increased risk of developing type 2 diabetes.
What each genotype means
Baseline diabetes risk
This genotype is considered the reference or baseline state for this variant. Research indicates that individuals with this profile do not carry the specific genetic risk factor associated with this SNP for type 2 diabetes.
This is a common genotype found in a significant portion of the general population.
Increased diabetes risk
Carrying one copy of the G allele is associated with a statistically increased risk of developing type 2 diabetes compared to those without the variant. This association suggests a moderate influence on metabolic health, though it is only one of many factors that contribute to overall risk.
This heterozygous genotype is commonly observed across various global populations.
Elevated diabetes risk
Individuals with two copies of the G allele show a higher statistical association with type 2 diabetes risk compared to those with one or no copies. While this genotype is linked to increased susceptibility, it does not guarantee the development of the condition, as lifestyle and other genetic factors play critical roles.
This homozygous genotype is present in a notable segment of the population, though it is less frequent than the heterozygous state.
What is the rs4655595 Variant?
A single nucleotide polymorphism, or SNP, is a variation at a single position in a DNA sequence among individuals. The variant rs4655595 is a specific location within the human genome where different people may carry different DNA letters. This SNP is situated within the TCF7L2 gene, a region that has been extensively studied for its role in metabolic health. When researchers identify a SNP like rs4655595, they look for statistical correlations between the specific DNA letters present at that site and certain health traits or conditions. In the case of rs4655595, large-scale genomic studies have consistently observed that certain versions of this variant appear more frequently in individuals who have been diagnosed with type 2 diabetes compared to those who have not. It is important to understand that this is a statistical association observed across large populations, rather than a direct cause-and-effect mechanism that determines an individual's health outcome.
The Role of the TCF7L2 Gene
The TCF7L2 gene provides instructions for making a protein that acts as a transcription factor. Transcription factors are proteins that bind to specific regions of DNA to help control the activity of other genes. The TCF7L2 protein is particularly important in the Wnt signaling pathway, which plays a critical role in the development and function of various tissues, including the pancreas. In the context of glucose metabolism, the TCF7L2 protein is involved in regulating the function of pancreatic beta cells, which are responsible for producing and secreting insulin. Insulin is the hormone that helps the body manage blood sugar levels. Research suggests that variations in the TCF7L2 gene may influence how these beta cells respond to glucose, potentially affecting insulin secretion. Because of its central role in these processes, TCF7L2 is considered one of the most significant genetic loci associated with the risk of type 2 diabetes.
Evidence and Research Associations
The association between TCF7L2 variants and type 2 diabetes is one of the most robust findings in the field of complex disease genetics. Since the initial discovery of this link, numerous studies across diverse populations—including European, Asian, and American cohorts—have replicated the finding that specific alleles in this gene are associated with an increased risk of developing the condition. The evidence strength for TCF7L2 as a susceptibility locus is considered moderate to high in the context of polygenic risk. While the presence of a risk allele is statistically linked to a higher likelihood of diabetes, it is not a diagnostic tool. Many people who carry the risk-associated version of the SNP never develop diabetes, and many who do not carry it still develop the condition. This highlights the polygenic nature of type 2 diabetes, where hundreds of genetic variants, each with a small effect, interact with lifestyle and environmental factors to influence overall risk.
Population Frequency
The rs4655595 variant is classified as a common SNP, meaning that the different versions of the DNA letter at this position are found frequently across most human populations. Because it is common, a large portion of the general population carries at least one copy of the risk-associated allele. The specific frequency of each genotype can vary depending on ancestral background, but it is not a rare mutation. This high prevalence is part of why the variant is so useful for researchers studying the genetic architecture of common diseases. By comparing the frequency of these alleles in large groups of people with and without diabetes, scientists can calculate the odds ratio, which helps quantify how much the variant contributes to the overall risk profile. Because the variant is so common, it is considered a standard component of many polygenic risk scores used in research settings to study metabolic health trends.
Interpreting Your Genetic Information
Understanding your genetic profile regarding variants like rs4655595 can be an educational experience, but it is important to maintain realistic expectations. Genetic information is only one piece of a much larger puzzle that includes diet, physical activity, age, and family history. You cannot use this information to diagnose yourself with a condition or to predict your future health with certainty. If you are concerned about your risk for type 2 diabetes, the most effective steps involve consulting with a healthcare professional. They can evaluate your clinical markers, such as blood glucose levels and body mass index, which are far more predictive of your current health status than any single SNP. Never make changes to your diet, exercise, or medication regimen based solely on genetic test results without first discussing them with your doctor or a qualified medical professional.
How common is this variant?
The rs4655595 variant is a common polymorphism found across diverse global populations, with its specific allele frequencies varying by ancestry.
Frequently asked questions
Does having the TCF7L2 risk allele mean I will get diabetes?
No. Genetic risk is not a diagnosis. Many people with the risk allele never develop diabetes, and many people without it do.
Can I change my TCF7L2 genotype?
No, your genotype is determined at conception and cannot be changed. However, you can manage your health through lifestyle choices like diet and exercise.
Should I get tested for this SNP?
Genetic testing for common variants like rs4655595 is generally not recommended for clinical diagnosis. Clinical tests like fasting blood glucose or HbA1c are the standard for assessing diabetes risk.
What is the difference between a gene and a SNP?
A gene is a segment of DNA that provides instructions for a protein. A SNP is a specific, single-letter variation within that DNA sequence.
Sources & further reading
Educational information only, last refreshed 10/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4655595?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TCF7L2
A variant identified in large consortium studies as a contributor to type-2 diabetes susceptibility.
This genetic variant is linked to altered glucose metabolism and increased risk of type-2 diabetes.
Variant in TCF7L2 consistently associated with altered pancreatic beta-cell function and predisposition to type 2 diabetes.
Resides within the TCF7L2 genomic locus, which is strongly linked to altered glucose regulation and type 2 diabetes susceptibility.
This variant is a well-established marker within the TCF7L2 locus, which is recognized as the most potent genetic risk factor for type 2 diabetes across multiple ethnic groups.
This variant is a well-established genetic marker in the TCF7L2 locus associated with impaired insulin secretion and increased risk of type 2 diabetes.